NIAGEN BIOSCIENCE, INC. (NAGE) Operating margin 2017–2025
NIAGEN BIOSCIENCE, INC. (NAGE) operating margin by fiscal year — reported operating income divided by reported revenue.
12.6%FY2025 · since FY2017: -77.2% → 12.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 12.6% | +4.8 pp |
| FY2024 | 7.8% | +14.5 pp |
| FY2023 | -6.7% | +19.2 pp |
| FY2022 | -25.9% | +14.3 pp |
| FY2021 | -40.1% | -6.6 pp |
| FY2020 | -33.5% | +34.1 pp |
| FY2019 | -67.6% | +37.5 pp |
| FY2018 | -105.1% | -27.9 pp |
| FY2017 | -77.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice